HomeStock ScreenerBacil PharmaQuarterly Results

Bacil Pharma Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹0 Cr
QMarch 2025
Quarterly Results

In March 2025, Bacil Pharma (BACPHAR) reported revenue ₹1 Cr and net profit ₹0 Cr. Compare with BACPHAR stock valuation models to assess whether the stock is under or overvalued.

BACPHAR Quarterly Results — Revenue, Profit & EPS Highlights

Bacil Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Bacil Pharma stock price NSE.

  • Revenue of ₹1 Cr in March 2025
  • Earnings Per Share of ₹0.64 in March 2025 (+740.0% vs March 2024)

Bacil Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

BACPHAR quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric March 2025 March 2024 March 2023 March 2022 March 2021 QoQ YoY
Revenue (₹ Cr) 1 0 0 0 0 - -
Net Profit (₹ Cr) 0 0 0 -4 0 - -
EBITDA (₹ Cr) 0 0 0 -4 0 - -
EPS (₹) 0.64 -0.10 -0.17 -6.55 -0.41 - -
Operating Margin (%) 0.0% 0.0% 0.0% 0.0% 0.0% - -

BACPHAR Share Price Trend — 1-Year Movement Across Quarterly Results

Bacil Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore BACPHAR price trends to track price trends across different timeframes.

Profitability Ratios

Balance Sheet Highlights

Total Assets ₹26 Cr
Total Equity ₹25 Cr
Current Assets ₹3 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹2 Cr
Net Cash Flow ₹3 Cr

Current Market Data

Current Price ₹51.09
Exchange BSE
Last Updated May 27, 2026

BACPHAR vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Bacil Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026
₹442,581.33 Cr 1844.3 15,018 2,710 +1.0% +11.8% 18.0% 163.2
Divis Laboratories
Mar 2026
₹179,363.85 Cr 6797.5 2,986 751 +4.4% +11.8% 25.2% 240.1
Torrent Pharmaceuti…
Mar 2026
₹153,579.77 Cr 4537.8 4,111 364 +27.7% +42.2% 8.9% 394.2
Cipla
Mar 2026
₹114,559.46 Cr 1418.2 6,612 543 -14.3% -4.0% 8.2% 206.4
Dr Reddys Laborator…
Mar 2026
₹110,089.41 Cr 1319.0 7,996 221 -12.5% -11.5% 2.8% 497.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores